Results for "alopecia areata"
Alopecia
** Alopecia is the medical term for hair loss from the scalp or body, ranging from small patches to complete baldness, and can have physical, emotional, and social consequences. **CONTENT:** ## Overview **Alopecia** describes any condition that leads to the loss of hair, most commonly from the scalp but occasionally from eyebrows, eyelashes, or other body sites. The pattern and extent of loss vary widely: some individuals notice a few thinning strands, while others experience **total scalp hair loss (alopecia totalis)** or loss of all body hair (**alopecia universalis**). In most forms, the hair follicles remain viable and the skin shows no signs of inflammation or scarring, distinguishing non‑scarring alopecia from conditions that permanently damage the follicle. The most prevalent type is **androgenetic alopecia**, often called male‑ or female‑pattern baldness, driven by genetic susceptibility and the hormone dihydrotestosterone (DHT). Other common forms include **alopecia areata**, an autoimmune attack that produces round, smooth patches of baldness, and **telogen effluvium**, a temporary shedding triggered by stress, illness, medication, or hormonal changes. While many cases are benign and self‑limiting, hair loss can provoke significant **psychological distress**, affecting self‑esteem, social interaction, and even leading to anxiety or depression. Early evaluation by a **dermatologist** or primary‑care provider is advisable when hair loss is rapid, patchy, painful, or accompanied by scalp changes, as these may signal underlying disease requiring prompt treatment. ## History/Background The word “alopecia” derives from the Greek *alopex*, meaning “fox,” a reference to the fox’s seasonal shedding of fur. Descriptions of hair loss appear in ancient Egyptian medical papyri (c. 1500 BCE) and Hippocratic writings, where physicians noted familial patterns and linked baldness to temperament. In the 19th century, French dermatologist **Jean‑Louis-Marc Alibert** coined “alopecia” as a distinct clinical entity, separating it from skin diseases. The early 20th century saw the first systematic classification of hair loss types, notably **Frederick W. Hamilton’s** 1942 “Hamilton‑Norwood scale” for male‑pattern baldness, still used today. The discovery of the role of androgens in the 1950s and the identification of **autoimmune mechanisms** in alopecia areata during the 1970s transformed both diagnostic and therapeutic approaches. Recent decades have introduced **finasteride**, **minoxidil**, and biologic agents, reflecting a shift from purely cosmetic management to targeted medical therapy. ## Key Information - **Types of alopecia** - *Androgenetic alopecia*: gradual miniaturization of follicles; most common, affecting up to 80 % of men and 50 % of women by age 50. - *Alopecia areata*: sudden, well‑circumscribed patches; 1–2 % prevalence; often associated with other autoimmune disorders. - *Telogen effluvium*: diffuse shedding 2–4 months after a trigger; usually resolves within 6 months. - *Scarring (cicatricial) alopecia*: permanent loss due to follicular destruction; requires early intervention. - **Diagnostic work‑up** includes a thorough history, physical examination, pull‑test, trichoscopy, and, when needed, scalp biopsy. Blood tests may screen for thyroid disease, iron deficiency, or hormonal imbalances. - **Treatment options** vary by etiology: - *Topical minoxidil* (2–5 % solutions) stimulates follicular blood flow. - *Oral finasteride* (1 mg daily) blocks DHT production in androgenetic alopecia. - *Intralesional corticosteroids* or topical immunotherapy for alopecia areata. - *Platelet‑rich plasma (PRP)* and low‑level laser therapy are emerging adjuncts. - *Hair transplantation* offers permanent restoration for stable androgenetic loss. - **Psychosocial support**: counseling, support groups, and cognitive‑behavioral therapy can mitigate the emotional impact. - **When to seek professional care**: sudden extensive shedding, scalp pain, itching, redness, or any hair loss accompanied by systemic symptoms (fever, weight loss) warrants prompt medical evaluation. ## Significance Alopecia extends beyond a cosmetic concern; it intersects dermatology, immunology, endocrinology, and mental health. The prevalence of androgenetic alopecia makes it one of the most common chronic conditions worldwide, influencing workplace confidence and interpersonal relationships. Autoimmune alopecia areata serves as a model for studying immune tolerance, informing research into other autoimmune diseases. Economically, the global hair‑loss treatment market exceeds **USD 10 billion**, reflecting both consumer demand and the pharmaceutical industry’s investment in novel therapeutics. Moreover, the visibility of public figures embracing baldness has helped destigmatize hair loss, fostering broader acceptance while also highlighting the need for equitable access to effective care. Continued research into follicular stem cells and gene‑editing holds promise for regenerative solutions that could one day reverse permanent alopecia, reshaping both clinical practice and societal attitudes toward hair loss. **INFOBOX:** - Name: Alopecia (Hair Loss) - Type: Medical condition / Dermatologic disorder - Date: Term coined in early 19th century (c. 1800) - Location: Affects scalp and/or body hair worldwide - Known For: Spectrum of hair‑loss patterns ranging from patchy baldness to total body hair loss **TAGS:** alopecia, hair loss, dermatology, androgenetic alopecia, alopecia areata, telogen effluvium, scalp health, psychological impact
Health & MedicineConditions Encyclopedia Entry 1776981784
Alopecia areata is a chronic autoimmune skin condition characterized by hair loss on the scalp, face, or body, with unpredictable patterns and varying degrees of severity.
Health & MedicineConditions Encyclopedia Entry 1778754187
Alopecia areata is a chronic autoimmune disorder that causes hair loss on the scalp and other parts of the body, resulting in patchy or complete baldness.